Kidney cancer therapies may improve quality of life

Kidney cancer drugs in development could improve patients' quality of life and allow more effective treatment, according to Robert Hawkins of Manchester University.

Change to kidney cancer drugs
Change to kidney cancer drugs

Drugs such as sunitinib have represented a 'step change' in kidney cancer treatment in the past few years, but have a number of side-effects, Professor Hawkins said.

These can be significant given that people take sunitinib for a year on average, but can be on the drug indefinitely, he said.

Professor Hawkins told GP newspaper that data on the developmental drug pazopanib suggested it had fewer 'off-target' effects than sunitinib.

'Pazopanib is much more specific which potentially leads to fewer side-effects,' he said.

'There are two likely benefits. One is that it will lead to a better quality of life. Also, patients may tolerate the treatment at a fuller dose for longer.'

He said patients often could not tolerate the maximum dose of sunitinib.

Promising data on regorafenib, another agent targeting the same receptor, were also presented at the conference.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

The RCGP and the Royal Pharmaceutical Society have called on GP practices and community...

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

Medical training and the future NHS workforce could be seriously damaged by the financial...

GPonline's news editor wins medical journalism award

GPonline's news editor wins medical journalism award

GPonline news editor Nick Bostock has won News Story of the Year (specialist media)...

How GPs can support patients with 'long COVID'

How GPs can support patients with 'long COVID'

GPs must be ready to support patients with physical, psychological and social problems...

BMA demands 'rule of six' overhaul to prevent further lockdowns

BMA demands 'rule of six' overhaul to prevent further lockdowns

The government must scrap its high-risk ‘rule of six’ and introduce more stringent...

Average GP practice list tops 9,000 after 30% rise in seven years

Average GP practice list tops 9,000 after 30% rise in seven years

The average GP practice list has risen beyond 9,000 patients for the first time after...